| References |
|
|
Alagille D,
Estrada A,
Hadchouel M et al.
(1987)
Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.
Journal of Pediatrics
110:
195–200.
|
|
|
Alagille D,
Odievre M,
Gautier M and
Dommergues JP
(1975)
Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur.
Journal of Pediatrics
86:
63–71.
|
|
|
Artavanis-Tsakonas S,
Delidakis C,
Fehon R et al.
(1990)
Notch and the molecular genetics of neuroblast segregation in Drosophila.
Molecular Reproduction and Development
27:
23–27.
|
|
|
Boyer J,
Crosnier C,
Driancourt C et al.
(2005)
Expression of mutant JAGGED1 alleles in patients with Alagille syndrome.
Human Genetics
116:
445–453.
|
|
|
Chen H,
Ko G,
Zatti A et al.
(2009)
Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both epsin 1 and epsin 2 in mice.
Proceedings of the National Academy of Sciences of the USA
106:
13838–13843.
|
|
|
book
Crawford JM
(2004)
"The intrahepatic biliary tree".
In: Bittar EE (ed.)
Principles of Medical Biology, vol.
15,
pp. 1–20.
Oxford, UK: Elsevier.
|
|
|
Crosnier C,
Attie-Bitach T,
Encha-Razavi F et al.
(2000)
JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome.
Hepatology
32:
574–581.
|
|
|
Dyack S,
Cameron M,
Otley A and
Greer W
(2007)
An autosomal recessive form of Alagille-like syndrome that is not linked to JAG1.
Genetics in Medicine
9:
544–550.
|
|
|
Geisler F,
Nagl F,
Mazur PK et al.
(2008)
Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.
Hepatology
48:
607–616.
|
|
|
Gridley T
(2003)
Notch signaling and inherited disease syndromes.
Human Molecular Genetics
12 Spec No 1: R9-R13.
|
|
|
High F,
Zhang M,
Proweller A et al.
(2007)
An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation.
Journal of Clinical Investigation
117:
353–363.
|
|
|
Hofmann JJ,
Zovein AC and
Iruela-Arispe L
(2009)
Endothelial and smooth muscle cell deletion of Jagged1 independently reconstitute the cardiac and hepatic defects of Alagille syndrome.
FASEB Journal
23:
116.2.
|
|
|
Iso T,
Hamamori Y and
Kedes L
(2003)
Notch signaling in vascular development.
Arteriosclerosis, Thrombosis, and Vascular Biology
23:
543–553.
|
|
|
Kamath BM,
Spinner NB,
Emerick KM et al.
(2004)
Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.
Circulation
109:
1354–1358.
|
|
|
Katoh M
(2007)
Notch signaling in gastrointestinal tract (review).
International Journal of Oncology
30:
247–251.
|
|
|
Kayhan A,
Ilkhchoui Y,
Venu N,
Jensen DM and
Oto A
(2010)
Multiple abdominal vascular anomalies in a patient with Alagille syndrome.
Journal of Vascular and Interventional Radiology
21:
937–940.
|
|
|
Kohsaka T,
Yuan ZR,
Guo SX et al.
(2002)
The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia.
Hepatology
36:
904–912.
|
|
|
Krantz ID,
Colliton RP,
Genin A et al.
(1998)
Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.
American Journal of Human Genetics
62:
1361–1369.
|
|
|
de La Coste A and
Freitas AA
(2006)
Notch signaling: distinct ligands induce specific signals during lymphocyte development and maturation.
Immunology Letters
102:
1–9.
|
|
|
LaVoie MJ and
Selkoe DJ
(2003)
The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments.
Journal of Biological Chemistry
278:
34427–34437.
|
|
|
Li L,
Krantz ID,
Deng Y et al.
(1997)
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.
Nature Genetics
16:
243–251.
|
|
|
Lindner V,
Booth C,
Prudovsky I et al.
(2001)
Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction.
American Journal of Pathology
159:
875–883.
|
|
|
Louvi A,
Arboleda-Velasquez JF and
Artavanis-Tsakonas S
(2006)
CADASIL: a critical look at a Notch disease.
Developmental Neuroscience
28:
5–12.
|
|
|
Louvi A and
Artavanis-Tsakonas S
(2006)
Notch signalling in vertebrate neural development.
Nature Reviews. Neuroscience
7:
93–102.
|
|
|
Lozier J,
McCright B and
Gridley T
(2008)
Notch signaling regulates bile duct morphogenesis in mice.
PLoS One
3:
e1851.
|
|
|
Matsuno K,
Eastman D,
Mitsiades T et al.
(1998)
Human deltex is a conserved regulator of Notch signalling.
Nature Genetics
19:
74–78.
|
|
|
McCright B,
Gao X,
Shen L et al.
(2001)
Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation.
Development
128:
491–502.
|
|
|
McCright B,
Lozier J and
Gridley T
(2002)
A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
Development
129:
1075–1082.
|
|
|
McDaniell R,
Warthen DM,
Sanchez-Lara PA et al.
(2006)
NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.
American Journal of Human Genetics
79:
169–173.
|
|
|
McElhinney DB,
Krantz ID,
Bason L et al.
(2002)
Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome.
Circulation
106:
2567–2574.
|
|
|
Miyamoto A,
Lau R,
Hein PW,
Shipley JM and
Weinmaster G
(2006)
Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation.
Journal of Biological Chemistry
281:
10089–10097.
|
|
|
Morrow D,
Cullen JP,
Cahill PA and
Redmond EM
(2007)
Cyclic strain regulates the Notch/CBF-1 signaling pathway in endothelial cells: role in angiogenic activity.
Arteriosclerosis, Thrombosis, and Vascular Biology
27:
1289–1296.
|
|
|
Morrow D,
Cullen JP,
Liu W et al.
(2009)
Sonic Hedgehog induces Notch target gene expression in vascular smooth muscle cells via VEGF-A.
Arteriosclerosis, Thrombosis, and Vascular Biology
29:
1112–1118.
|
|
|
Morrow D,
Guha S,
Sweeney C et al.
(2008)
Notch and vascular smooth muscle cell phenotype.
Circulation Research
103:
1370–1382.
|
|
|
Morrow D,
Scheller A,
Birney YA et al.
(2005)
Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro.
American Journal of Physiology. Cell Physiology
289:
C1188–C1196.
|
|
|
Niessen K and
Karsan A
(2007)
Notch signaling in the developing cardiovascular system.
American Journal of Physiology. Cell Physiology
293:
C1–C11.
|
|
|
Oda T,
Elkahloun AG,
Pike BL et al.
(1997)
Mutations in the human Jagged1 gene are responsible for Alagille syndrome.
Nature Genetics
16:
235–242.
|
|
|
Piccoli DA and
Spinner NB
(2001)
Alagille syndrome and the Jagged1 gene.
Seminars in Liver Disease
21:
525–534.
|
|
|
Pollet N,
Boccaccio C,
Dhorne-Pollet S et al.
(1997)
Construction of an integrated physical and gene map of human chromosome 20p12 providing candidate genes for Alagille syndrome.
Genomics
42:
489–498.
|
|
|
Rampal R,
Luther KB and
Haltiwanger RS
(2007)
Notch signaling in normal and disease states: possible therapies related to glycosylation.
Current Molecular Medicine
7:
427–445.
|
|
|
Roca C and
Adams RH
(2007)
Regulation of vascular morphogenesis by Notch signaling.
Genes & Development
21:
2511–2524.
|
|
|
Ryan MJ,
Bales C,
Nelson A et al.
(2008)
Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.
Hepatology
48:
1989–1997.
|
|
|
Small D,
Kovalenko D,
Kacer D et al.
(2001)
Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype.
Journal of Biological Chemistry
276:
32022–32030.
|
|
|
Sousa AB,
Medeira A,
Kamath BM,
Spinner NB and
Cordeiro I
(2006)
Familial stenosis of the pulmonary artery branches with a JAG1 mutation.
Revista Portuguesa de Cardiologia
25:
447–452.
|
|
|
Sparks EE,
Huppert KA,
Brown MA,
Washington MK and
Huppert SS
(2010)
Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice.
Hepatology
51:
1391–1400.
|
|
|
Spinner NB,
Rand EB,
Fortina P et al.
(1994)
Cytologically balanced t(2;20) in a two-generation family with Alagille syndrome: cytogenetic and molecular studies.
American Journal of Human Genetics
55:
238–243.
|
|
|
Watson GH and
Miller V
(1973)
Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.
Archives of Disease in Childhood
48:
459–466.
|
|
|
Xue Y,
Gao X,
Lindsell CE et al.
(1999)
Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.
Human Molecular Genetics
8:
723–730.
|
| Further Reading |
|
|
Chabriat H,
Joutel A,
Dichgans M,
Tournier-Lasserve E and
Bousser MG
(2009)
Cadasil.
Lancet Neurology
8:
643–653.
|
|
|
Crosnier C,
Lykavieris P,
Meunier-Rotival M and
Hadchouel M
(2000)
Alagille syndrome. The widening spectrum of arteriohepatic dysplasia.
Clinics in Liver Disease
4:
765–778.
|
|
|
Hadchouel M
(2002)
Alagille syndrome.
Indian Journal of Pediatrics
69:
815–818.
|
|
|
Kamath BM,
Munoz PS,
Bab N et al.
(2010)
A longitudinal study to identify laboratory predictors of liver disease outcome in Alagille syndrome.
Journal of Pediatric Gastroenterology and Nutrition
50:
526–530.
|
|
|
Kim BJ and
Fulton AB
(2007)
The genetics and ocular findings of Alagille syndrome.
Seminars in Ophthalmology
22:
205–210.
|
|
|
Siekmann AF,
Covassin L and
Lawson ND
(2008)
Modulation of VEGF signalling output by the Notch pathway.
BioEssays
30:
303–313.
|
|
|
Zanotti S and
Canalis E
(2010)
Notch and the skeleton.
Molecular and Cellular Biology
30:
886–896.
|
